Health
New anti-cancer drug breakthrough for prostate cancer – Mirage News
Novel anti-cancer agents induce the degradation of the c-Met oncoprotein in the lysosome as demonstrated by confocal microscopy in tumour cells A new…
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
“The current gold standard for prostate cancer treatment …
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General20 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
General12 hours agoWork to do: net-zero jobs yet to resonate in classroom